Star Imaging & Path Lab last traded at ₹76.18 (2026-10-13). Over the past month the stock moved -6.0%, three months the stock moved +6.0%, year the stock moved -42.3%. Its closing range over 52 weeks is ₹46.29 – ₹147.90, with the latest close 48.5% below the high.
Closing prices up to 2026-10-13.
Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests.[1]
Business Profile[1] Star Imaging and Path Lab Limited (originally Janta X-Ray Clinic) is a Delhi-based diagnostic healthcare service provider offering pathology, radiology, cardiology, and neurology services. The company operates through B2C, B2B, and B2G models, with NABL-accredited facilities.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 43.00 | 16.00 | 37.00 | 9.00 | 5.30 |
| Sep 2025 | 45.00 | 17.00 | 38.00 | 10.00 | 5.77 |
| Mar 2025 | 41.00 | 17.00 | 41.00 | 10.00 | 7.19 |
| Sep 2024 | 43.00 | 12.00 | 27.00 | 6.00 | 41.40 |
In the latest year (Mar 2026), Star Imaging & Path Lab reported sales of ₹89.00 crore (+6.0%) and net profit of ₹19.00 crore (+18.8%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 89.00 | 33.00 | 37.00 | 19.00 | 11.07 |
| Mar 2025 | 84.00 | 29.00 | 35.00 | 16.00 | 11.80 |
| Mar 2024 | 79.00 | 23.00 | 30.00 | 12.00 | 82.80 |
| Mar 2023 | 58.00 | 6.00 | 10.00 | 1.00 | 3.87 |
| Mar 2022 | 69.00 | 15.00 | 21.00 | 6.00 | 41.93 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales growth | -15.9% | +36.2% | +6.3% | +6.0% |
| Operating profit growth | -60.0% | +283.3% | +26.1% | +13.8% |
| Net profit growth | -83.3% | +1100.0% | +33.3% | +18.8% |
| EPS growth | -90.8% | +2039.5% | -85.7% | -6.2% |
| OPM % | 10.0% | 30.0% | 35.0% | 37.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Star Imaging & Path Lab.
Get Free AI Stock Analysis FREE →No recent news available for Star Imaging & Path Lab.
Star Imaging & Path Lab shares were last quoted at ₹76.18 (-1.1% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Star Imaging & Path Lab has a price-to-earnings (P/E) ratio of 6.97 and a price-to-book (P/B) ratio of 1.16. The industry P/E is 101.02.
The 52-week high of Star Imaging & Path Lab is ₹152.00 and the 52-week low is ₹46.00.
The market capitalisation of Star Imaging & Path Lab is about ₹134.13 crore.
This page is for information and is not investment advice. As per the data shown here, Star Imaging & Path Lab has a 3-year ROE of 32.00%, 3-year profit growth of 222.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 71.92% of Star Imaging & Path Lab.
Star Imaging & Path Lab belongs to the Labs & Life Sciences Services sector.
All Labs & Life Sciences Services stocks · Browse all stocks A–Z